trending Market Intelligence /marketintelligence/en/news-insights/trending/wrgh9cm8td6no2e55l1x5q2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Aradigm adds ContraVir Pharmaceuticals COO to board

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Blog

COVID-19 Impact & Recovery: Investment Banking


Aradigm adds ContraVir Pharmaceuticals COO to board

Aradigm Corp. said July 6 that Theresa Matkovits was added to its board.

Matkovits is with ContraVir Pharmaceuticals Inc., where she has been COO since December 2017. Prior to her COO role, she was ContraVir's executive vice president and head of drug development.

Hayward, Calif.-based Aradigm is a specialty pharmaceutical company that develops and commercializes medicines to prevent and treat severe respiratory diseases.